Julie Brown was Appointed as Chief Financial Officer at GlaxoSmithKline

Date of management change: September 26, 2022 

What Happened?

Philadelphia, PA-based GlaxoSmithKline Appointed Julie Brown as Chief Financial Officer

 

About the Company

We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization`s three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. Our product portfolio also includes a range of consumer brands, many of which are household names around the world, including Sensodyne, Aquafresh, Horlicks, Panadol and Tums.

 

About the Person

Julie Brown is Chief Financial Officer at GlaxoSmithKline. Previously, Julie held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Best Deborah, Hall Kayla, Griffin Tracey, Roy Carol, Rodgers Elliott, Golden Erica, Etheridge Carol, Kasser Michael, Streil Christian, Garcia Veronica, Moore Kimer

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.